Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2500${count})

  • Research Grant, 2025
    The BioFINDER Studies: Identifying Disease Stages and Effects of Co-morbidities in Neuronal Synuclein Disease

    Study Rationale: Neuronal synuclein disease (NSD) is the underlying cause of Parkinson’s disease (PD) and similar disorders. Recently, new tests have allowed us to measure signs of NSD before symptoms...

  • Spring 2022 RFA: Therapeutic Pipeline Program Pre-Clinical, 2024
    Exploring Paxalisib as a Novel Therapeutic for Parkinson’s Disease

    Study Rationale: Studies in preclinical models of Parkinson’s disease (PD) and in postmortem PD brains suggest that a signaling pathway that is switched on by activation of a protein called...

  • ASAP CRN Competitive Renewal Opportunity, 2024
    Investigating How Alpha-synuclein-rich Neurons in Olfactory Circuits Respond to Environmental Triggers at the Initiation of Parkinson Disease
    ASAP logo

    Study Rationale: To slow the progression of Parkinson disease (PD), we need to understand how, where and why the illness starts. It is estimated that most individuals with PD experience a significant...

  • iPSC Phenotyping Environmental Exposure Program, 2025
    Assessing How Triplication of the Alpha-synuclein Gene Affects Electrophysiological and Mitochondrial Phenotypes in Neurons, Astrocytes and Microglia

    Study Rationale: One common familial inherited form of Parkinson’s disease (PD) is caused by triplication of SNCA, the gene that encodes the protein alpha-synuclein. Alpha-synuclein forms toxic...

  • Research Grant, 2024
    Determining Optimal Cognitive Measures and Clinical Trial Endpoints in Lewy Body Disorders

    Study Rationale: People with Lewy body disorders, including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), often experience cognitive impairment that can impact function, independence...

  • , 2024
    Epigenetic Analysis of Peripheral Immunity in Parkinson’s Disease

    Study Rationale: Parkinson’s disease (PD) has increasingly been linked to dysfunction in the immune system, with evidence showing abnormal activity in blood immune cells and their potential role in...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.